🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact Tourniquet Conservative Placenta Accreta Neonatal APGAR

RecruitingNAAges 20 Years - 40 YearsFemaleKasr El Aini Hospital
NCT07412925 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Placenta accreta spectrum disorder (PAS) refers to a condition where the placenta fails to separate naturally after childbirth, which can cause significant maternal and neonatal complications, including severe bleeding, leading to increased morbidity and mortality. According to the pathological characteristics, PAS can be classified into three categories, including placenta accreta, placenta increta, and placenta percreta. Risk factors for PAS were identified as cesarean section (CS), hysteroscopy history, in vitro fertilization and embryo transfer and placenta previa, etc. It was reported that over 90% of the PAS cases were with prior cesarean delivery. In order to reduce the morbidity and mortality caused by PAS, guidelines were released from several international societies, including the Federation of Gynecology and Obstetrics (FIGO), Royal College of Obstetricians and Gynecologists (

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age: 20-40 years old. 2. Pregnancy of a singleton living fetus. 3. Gestational age: pregnancy completing 34 weeks or more. 4. Previous one or more cesarean delivery. 5. Current pregnancy complicated by Placena Accreta Spectrum Disorder candidate for conservative managment either total or partial Placenta Accreta. 6. Elective termination of pregnancy. (35-37 weeks) 7. Preoperative Hemoglobin ≥ 10 g/dl. Exclusion Criteria: * 1-Patients who refuse to participate in the study. 2-Women with history of a concomitant chronic or a pregnancy associated medical disorder eg. Gestational diabetes, hypertension, cardiac or renal disease. 3-Presence of a concomitant uterine pathology (eg. Uterine fibroid) 4-Premature rupture of membranes. 5-Cases misdiagnosed as placenta accreta by ultrasound preoperatively, and spontaneous full placental separation occurred intraoperative or as total/partial accreta and found to be focal accreta intraoperative. 6-Cases requiring preoperative blood transfusion. 7- Any fetal abnormality e.g IUGR or SGA
💊

What it tests

  • Application Of A Tourniquet Around the lower segment of the uterus
  • Placenta Accreta spectrum conservative management
📍

Where

1 site
kasr Al Aini Hospitals , Faculty of medicine , Cairo University , Cairo
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy